CD8A and endometrial cancer: Activated CD8+ TIL in endometrial cancer barely produced IL-13 (1.06%), but they did produce GM-CSF (median 26.08%) and, to a lesser extent, IL-21 (median 8.79%) and very little IL-10 (median 3.7%) (Figure 5D).